Tametraline: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{Short description|Overview of the chemical compound Tametraline}} | |||
{{DISPLAYTITLE:Tametraline}} | |||
== | ==Overview== | ||
Tametraline was | [[File:Tametraline.svg|thumb|right|Chemical structure of Tametraline]] | ||
'''Tametraline''' is a chemical compound that was initially developed as a potential [[antidepressant]]. It belongs to the class of [[tetracyclic antidepressants]], which are known for their unique chemical structure and mechanism of action. Although Tametraline itself was never marketed, it served as a precursor to the development of other significant antidepressants. | |||
== | ==Chemical Structure== | ||
Tametraline | Tametraline is characterized by its tetracyclic structure, which consists of four interconnected rings. This structure is crucial for its pharmacological activity. The compound's chemical formula is C16H19N, and it has a molecular weight of 225.33 g/mol. | ||
== | ==Pharmacology== | ||
Tametraline | Tametraline functions primarily as a [[norepinephrine]] and [[dopamine]] reuptake inhibitor. This means it increases the levels of these neurotransmitters in the brain by preventing their reabsorption into neurons. This mechanism is thought to contribute to its potential antidepressant effects. | ||
== | ==Development and Derivatives== | ||
Although Tametraline itself was not marketed, its development led to the creation of other antidepressants, most notably [[sertraline]], which is widely used today. Sertraline, marketed under the brand name Zoloft, is a selective [[serotonin]] reuptake inhibitor (SSRI) and is one of the most commonly prescribed antidepressants. | |||
* [[ | |||
==Clinical Significance== | |||
The study of Tametraline and its derivatives has contributed significantly to the understanding of antidepressant pharmacology. By exploring the effects of Tametraline on neurotransmitter systems, researchers have gained insights into the treatment of [[depression]] and other mood disorders. | |||
==Related pages== | |||
* [[Antidepressant]] | |||
* [[Sertraline]] | * [[Sertraline]] | ||
* [[ | * [[Norepinephrine]] | ||
* [[Dopamine]] | |||
* [[Tetracyclic antidepressant]] | |||
[[ | |||
[[ | |||
[[Category:Tetracyclic antidepressants]] | |||
[[Category:Chemical compounds]] | |||
Latest revision as of 03:46, 13 February 2025
Overview of the chemical compound Tametraline
Overview[edit]
Tametraline is a chemical compound that was initially developed as a potential antidepressant. It belongs to the class of tetracyclic antidepressants, which are known for their unique chemical structure and mechanism of action. Although Tametraline itself was never marketed, it served as a precursor to the development of other significant antidepressants.
Chemical Structure[edit]
Tametraline is characterized by its tetracyclic structure, which consists of four interconnected rings. This structure is crucial for its pharmacological activity. The compound's chemical formula is C16H19N, and it has a molecular weight of 225.33 g/mol.
Pharmacology[edit]
Tametraline functions primarily as a norepinephrine and dopamine reuptake inhibitor. This means it increases the levels of these neurotransmitters in the brain by preventing their reabsorption into neurons. This mechanism is thought to contribute to its potential antidepressant effects.
Development and Derivatives[edit]
Although Tametraline itself was not marketed, its development led to the creation of other antidepressants, most notably sertraline, which is widely used today. Sertraline, marketed under the brand name Zoloft, is a selective serotonin reuptake inhibitor (SSRI) and is one of the most commonly prescribed antidepressants.
Clinical Significance[edit]
The study of Tametraline and its derivatives has contributed significantly to the understanding of antidepressant pharmacology. By exploring the effects of Tametraline on neurotransmitter systems, researchers have gained insights into the treatment of depression and other mood disorders.
